Alzamend Neuro (ALZN) Cash from Financing Activities (2020 - 2026)
Alzamend Neuro's Cash from Financing Activities came in at $8.02 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 98.7% from $4.04 million a year earlier and up 908.9% from the prior quarter.
Alzamend Neuro (ALZN) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, Alzamend Neuro reported Cash from Financing Activities of $8.81 million, down 29.6% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $4.83 million, down 53.7% from FY2025.
- Cash from Financing Activities carries a five-year compound annual growth rate of 1.7% (FY2021 to FY2026).
- Going back by fiscal year, Cash from Financing Activities was $10.44 million in FY2025 (+185.9%), $3.65 million in FY2024, $200.00 in FY2023 (-100.0%) and $18.85 million in FY2022 (+323.7%).
- The fiscal Q1 2027 figure represents the highest quarterly Cash from Financing Activities since fiscal Q1 2022.
- Year-over-year, Cash from Financing Activities increased in two of the last five quarters, with growth averaging 17.6%.
- The fastest year-over-year change in Cash from Financing Activities over five years came in fiscal Q1 2026 (growth of 105.5%), and the weakest in fiscal Q3 2022 (a decline of 100.0%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -47.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Alzamend Neuro | 6.37 Mn | 6.37 Mn | - | 8.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 8.02 Mn |
| Apr 30, 2026 | 794,844.00 |
| Jul 31, 2025 | 4.04 Mn |
| Apr 30, 2025 | 1.49 Mn |
| Jan 31, 2025 | 688,700.00 |
| Oct 31, 2024 | 6.30 Mn |
| Jul 31, 2024 | 1.96 Mn |
| Apr 30, 2024 | 1.52 Mn |
| Jan 31, 2024 | 2.11 Mn |
| Apr 30, 2022 | 3.94 Mn |
| Jan 31, 2022 | 400.00 |
| Oct 31, 2021 | 700.00 |
| Jul 31, 2021 | 14.91 Mn |
| Apr 30, 2021 | 3.15 Mn |
| Jan 31, 2021 | 841,008.00 |
| Oct 31, 2020 | 385,673.00 |
| Jul 31, 2020 | 77,010.00 |
Alzamend Neuro Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();